Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D001919:Bradycardia / Q000139:chemically induced; D002490:Central Nervous System / Q000187:drug effects; D003863:Depression / Q000139:chemically induced; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000139:chemically induced; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007022:Hypotension / Q000139:chemically induced; D011433:Propranolol / Q000008:administration & dosage / Q000009:adverse effects; D012119:Respiration / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D011433:Propranolol